Angitia Incorporated Limited
Clinical trials sponsored by Angitia Incorporated Limited, explained in plain language.
-
New drug aims to fortify fragile bones in brittle bone disease trial
Disease control Recruiting nowThis study tests a new medicine called AGA2115 in adults with osteogenesis imperfecta (brittle bone disease) types I, III, or IV. The goal is to see if it safely increases bone density compared to a placebo. About 80 adults aged 18 to 75 will participate, and the main measure is …
Phase: PHASE2 • Sponsor: Angitia Incorporated Limited • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
Healthy volunteers help test new drug's journey through the body
Knowledge-focused Recruiting nowThis early-phase study looks at how a single dose of AGA2118 moves through and leaves the body in 30 healthy adults of Japanese, Chinese, and Caucasian descent. Participants must be 18-65, have adequate vitamin D levels, and agree to take calcium and vitamin D supplements. The st…
Phase: PHASE1 • Sponsor: Angitia Incorporated Limited • Aim: Knowledge-focused
Last updated May 11, 2026 20:50 UTC